Luther King Capital Management (LKCM)’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-3,300
Closed -$702K 584
2014
Q4
$702K Hold
3,300
0.01% 404
2014
Q3
$588K Hold
3,300
﹤0.01% 437
2014
Q2
$558K Buy
3,300
+1,350
+69% +$210K ﹤0.01% 443
2014
Q1
$242K Buy
+1,950
New +$237K ﹤0.01% 495
2013
Q4
Sell
-17,860
Closed -$1.61M 690
2013
Q3
$1.61M Sell
17,860
-495,705
-97% -$44.5M 0.01% 370
2013
Q2
$43.3M Buy
+513,565
New +$53.3M 0.4% 79

Other funds holding AGN

Luther King Capital Management (LKCM)'s AGN Position: Q1 2015 in Review

Luther King Capital Management (LKCM) sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,300 shares — an estimated $702K sold.

Luther King Capital Management (LKCM) first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $43.3M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Luther King Capital Management (LKCM) reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 3,300 Allergan Inc shares in Q1 2015, an estimated $702K.
  • Luther King Capital Management (LKCM) first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Luther King Capital Management (LKCM)'s Allergan Inc position peaked at $43.3M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2015, filed 14 May 2015.